CD4 and cancer: By secreting IL-2, TNFα, and IFN-γ, Th1-polarized CD4+ T cells play a relevant role in anti-tumor immunity [27,28,29,30], including in NMSCs [31,32,33], and may predicate the success of anti-cancer immune therapy [34,35].